Delivery Order SPE2DB24D1205-SPE2DB25FDABZ
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $48,737.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $24.4K and is structured as a firm fixed price delivery order, with an ultimate completion date of September 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of AYVAKIT 25 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $73,106.76, is scheduled for completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product AYVAKIT 25 MG TABLET 30S. The order has a ceiling value of $23,325.68 and is a firm fixed-price contract. The ultimate completion date for this delivery order is August 27, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a potential value of up to...
- The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT 25 mg tablets (30-count packages) under a firm fixed-price contract. The award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive delivery order executed by the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This order falls under AmerisourceBergen's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of the pharmaceutical product AYVAKIT 25 MG TABLET 30S. The contract has a ceiling value of $23,325.68 and is a firm-fixed-price contract. The period of performance extends through October 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packaging) under a firm fixed price contract valued at approximately $24.4K. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- This delivery order, awarded to AmerisourceBergen Drug Corp on August 18, 2025, provides for the supply of AYVAKIT 25 mg tablets (30-count units) valued at $24,368.92 with a completion date of September 9, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, awarded competitively through the Defense Logistics Agency (DLA), which procures medical supplies for the Department of Defense. Performance will be conducted from the contractor's corporate office in...
- This federal contract award, valued at $48,737.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of the medication AYVAKIT 25 MG TABLET 30S, with a performance period ending on May 8, 2025. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The order is for the pharmaceutical product AYVAKIT 200 MG TABLET 30S, with a ceiling value of $22,692.75 and a performance period ending on October 30, 2024. The contract is a Firm Fixed Price type. This order is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDABZDelivery Order
The Defense Logistics Agency awarded a $24,368.92 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This delivery order, issued without set-aside designation, is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AYVAKIT is a tyrosine kinase inhibitor used in the treatment of gastrointestinal stromal tumors, representing a specialized pharmaceutical product within the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. As a major pharmaceutical distributor and the prime contractor under this IDC, AmerisourceBergen Drug Corp serves federal healthcare systems including the Defense Health Agency and U.S. Coast Guard, with all reviewed contract awards demonstrating competitively awarded status and firm fixed pricing structures across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 9/3/25 |